Instituto de Cardiología y Medicina Vascular (@cardiotecdemty) 's Twitter Profile
Instituto de Cardiología y Medicina Vascular

@cardiotecdemty

Instituto de Cardiología y Medicina Vascular del @tecsaludMX

ID: 1681782423183343618

linkhttp://content.tecsalud.mx/cardiologia calendar_today19-07-2023 21:46:21

41 Tweet

92 Followers

106 Following

Instituto de Cardiología y Medicina Vascular (@cardiotecdemty) 's Twitter Profile Photo

Dosis bajas de Colchicina para prevención secundaria de enfermedad arterial coronaria: JACC Review Topic of the Week | Journal of the American College of Cardiology jacc.org/doi/10.1016/j.… #jacc #prevencion #cardiologia Sociedad Mexicana de Cardiología

Dosis bajas de Colchicina para prevención secundaria de enfermedad arterial coronaria: JACC Review Topic of the Week | Journal of the American College of Cardiology jacc.org/doi/10.1016/j.…
#jacc #prevencion #cardiologia <a href="/smexcardiologia/">Sociedad Mexicana de Cardiología</a>
Harriette Van Spall, MD MPH (@hvanspall) 's Twitter Profile Photo

Superb review led by ⁦Shahzeb Khan⁩ ⁦Javed Butler⁩ et al. So wonderful to collaborate with friends #ArtificialIntelligence and #HeartFailure: A State‐of‐the‐Art Review. Steve Greene⁩ ⁦ambarish⁩ onlinelibrary.wiley.com/doi/10.1002/ej…

Juan Pablo Costabel MD 🇦🇷 (@jpcostabel) 's Twitter Profile Photo

In analyses adjusted for factors associated with their placement, Swan Ganz use was associated with lower mortality in all shock patients admitted to a CICU (OR: 0.79 [95% CI: 0.66-0.96]; P = 0.017). Do you feel this statemente is wright? ☝️ I do!! sciencedirect.com/science/articl…

In analyses adjusted for factors associated with their placement, Swan Ganz use was associated with lower mortality in all shock patients admitted to a CICU (OR: 0.79 [95% CI: 0.66-0.96]; P = 0.017).
Do you feel this statemente is wright?
☝️ I do!! 
sciencedirect.com/science/articl…
Sarah Hudson (@sarahhudsonuk) 's Twitter Profile Photo

Ten current papers for the curious general cardiologist, including ticagrelor monotherapy post PCI, MRA use in cardiac amyloid, asystole post shock from wearable defibs & ⬇️in mortality using telemonitoring in HF Sources: European Society of Cardiology Journals, JACC Journals, JAMA Cardiology 1/n

Ten current papers for the curious general cardiologist, including ticagrelor monotherapy post PCI, MRA use in cardiac amyloid, asystole post shock from wearable defibs &amp; ⬇️in mortality using telemonitoring in HF

Sources: <a href="/ESC_Journals/">European Society of Cardiology Journals</a>, <a href="/JACCJournals/">JACC Journals</a>, <a href="/JAMACardio/">JAMA Cardiology</a> 

1/n
Instituto de Cardiología y Medicina Vascular (@cardiotecdemty) 's Twitter Profile Photo

La prevención primordial es la clave de una vida saludable, esta cambia el rumbo de las enfermedades Cardiovasculares #cardiologia #cardiology #cardiotwitter #esccongress #esccardioed

Diego Segura-Rodríguez (@seguracardio) 's Twitter Profile Photo

Las últimas guías 2023 de la European Society of Cardiology en un solo hilo 🧵‼️👇🏼 🔸Síndrome Coronario Agudo 🔸Miocardiopatías 🔸Endocarditis 🔸Enfermedad CV & Diabetes 🔸Actualización de Insuficiencia Cardiaca A estudiar toca‼️😉 Compártelo con tus contactos👥

JACC Journals (@jaccjournals) 's Twitter Profile Photo

Time to Tx high #CAC as aggressively as post-heart attack? CAC of ≥300 in asymptomatic ppl confers the same risk as post-MI survivors (eg secondary prevention) in #CONFIRM. Use of CAC may guide the intensity of preventive approaches more broadly. bit.ly/461l9zQ #JACCIMG

Time to Tx high #CAC as aggressively as post-heart attack? CAC of ≥300 in asymptomatic ppl confers the same risk as post-MI survivors (eg secondary prevention) in #CONFIRM. Use of CAC may guide the intensity of preventive approaches more broadly. bit.ly/461l9zQ #JACCIMG
Erasmo DLP (@erasmopa) 's Twitter Profile Photo

El Dr Juan Quintanilla, Director de Cardiologia Intervencionista en el Instituto de Cardiologia y Medicina Vascular Instituto de Cardiología y Medicina Vascular TecSalud - Sistema de Salud del Tec de Monterrey en su ponencia magistral en el congreso heartmonterrey.com en choque cardiogenico y la iniciativa de Choque de Tecsalud

El Dr Juan Quintanilla, Director de Cardiologia Intervencionista en el Instituto de Cardiologia y Medicina Vascular <a href="/cardiotecdemty/">Instituto de Cardiología y Medicina Vascular</a>  <a href="/TecSaludMX/">TecSalud - Sistema de Salud del Tec de Monterrey</a>  en su ponencia magistral en el congreso heartmonterrey.com en choque cardiogenico y la iniciativa de Choque de Tecsalud